Medical Device Investing Abbott Receives Expanded Medicare Reimbursement for First-Of-Its-Kind MitraClip Device
Psychedelics Investing MindMed Announces the Start of the First-Ever Clinical Trial Combining MDMA and LSD
Medical Device Investing Bausch + Lomb Announces Scientific Data On Bausch + Lomb INFUSE Silicone Hydrogel Daily Disposable Contact Lenses To Be Presented At The Virtual Global Specialty Lens Symposium
U.S. Food and Drug Administration Accepts for Priority Review Application for Opdivo® as Adjuvant Therapy for Patients with Resected Esophageal or Gastroesophageal Junction Cancer
U.S. Food and Drug Administration Accepts for Priority Review Application for Opdivo® Combined with Chemotherapy as First-Line Treatment in Metastatic Gastric Cancer, Gastroesophageal Junction Cancer and Esophageal Adenocarcinoma
Algernon Pharmaceuticals Receives Green Light from DSMB to Conduct Phase 3 Study of Ifenprodil for COVID-19
Medical Device Investing Thermo Fisher Scientific to Acquire Point-of-Care Molecular Diagnostics Provider Mesa Biotech
Radiopharm Theranostics Doses First Patient with 18F-RAD101 in U.S. Phase 2b Imaging Study of Brain MetastasisÂ
